Neurotropin - Argenes/Nippon Zoki

Drug Profile

Neurotropin - Argenes/Nippon Zoki

Alternative Names: Fibromylagia therapy - Argenes/Nippon Zoki; Neurotropin

Latest Information Update: 16 Nov 2006

Price : $50

At a glance

  • Originator Nippon Zoki
  • Class Non-opioid analgesics; Polysaccharides
  • Mechanism of Action Alpha 2 adrenergic receptor agonists; Serotonin 3 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Neuropathic pain

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top